The pressure to provide novel therapeutics to people is constantly rising, and biopharmaceutical companies are increasingly turning to specialized research and creation offerings to accelerate the entire process. These services encompass a broad spectrum of capabilities, from early-stage target selection and lead refinement to pre-clinical studies,